Abstract
Objectives
Aimed to demonstrate the association of VC and metabolism in the obesity or overweight and determine VC changes after laparoscopic sleeve gastrectomy (LSG).
Methods
A total of 253 overweight or people with obesity were recruited, including 61 with LSG. They were divided into group A (VC < 34 ug/ml) and group B (VC ≥ 34 ug/ml). Glucose-lipid metabolic parameters were compared, and VC status before and 6 and 12 months after LSG were measured.
Results
(1) Body weight, body mass index (BMI), neck circumference (NC), waist circumference (WC), hip circumference (HC), waist-to-hip ratio, heart rate (HR), diastolic systolic pressure (DBP), 2-hour postprandial glucose (2h-BG), fasting insulin (FINS), 2-hour postprandial insulin (2h-INS), glycosylated hemoglobin (HBG), homeostasis model of insulin resistance (HOMA-IR), total cholesterol (TCH), triglyceride (TG) and free fatty acid (FFA) were higher while high-density lipoprotein (HDL-C) was lower in group A than group B (p < 0.05). (2) VC was negatively correlated with body weight, BMI, NC, WC and HC, HR, SBP, DBP, and 2h-BG, FINS, 2h-INS, HGB, HOMA-IR, TG and FFA, while positively with HDL-C (p < 0.05). (3) Patients with obesity or hypertriglyceridemia or low HDL-C had lower VC than corresponding group. (p < 0.05). (4) Logistic regression analysis showed that VC was the independent risk factor of hypertriglyceridemia, obesity and low HDL-C 5) VC concentrations were slightly increased in 6 months after LSG, and unchanged in 12 months after LSG.
Conclusion
VC was closely associated with glucose-lipid metabolism, and may play a protective role in metabolic disorders. LSG would not worsen the VC status or deficiency.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
WHO, 2018. Obesity and Overweight. Fact Sheet N。311. World Health Organization, Geneva.
Hales CM, Fryar CD, Carroll MD, Freedman DS, Aoki Y, Ogden CL. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013-2016. Jama. 2018;319:2419–29.
Lu J, Bi Y, Ning G. Curbing the obesity epidemic in China. Lancet Diabetes Endocrinol. 2016;4:470–1.
Ma B, Sun H, Zhu B, Wang S, Du L, Wang X, et al. Hepatic steatosis is associated with elevated serum iron in patients with obesity and improves after laparoscopic sleeve gastrectomy. Obes Facts. 2021;14:64–71.
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Investig. 2017;127:1–4.
Thomas-Valdés S, Tostes M, Anunciação PC, da Silva BP, Sant’Ana HMP. Association between vitamin deficiency and metabolic disorders related to obesity. Crit Rev food Sci Nutr. 2017;57:3332–43.
Aasheim ET, Hofsø D, Hjelmesaeth J, Birkeland KI, Bøhmer T. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr. 2008;87:362–9.
Landrier JF, Marcotorchino J, Tourniaire F. Lipophilic micronutrients and adipose tissue biology. Nutrients. 2012;4:1622–49.
Johnston CS. Strategies for healthy weight loss: from vitamin C to the glycemic response. J Am Coll Nutr. 2005;24:158–65.
Senen D, Adanali G, Ayhan M, Görgü M, Erdogan B. Contribution of vitamin C administration for increasing lipolysis. Aesthetic Plast Surg. 2002;26:123–5.
Garcia-Diaz DF, Campion J, Milagro FI, Boque N, Moreno-Aliaga MJ, Martinez JA. Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes. J Mol Endocrinol. 2010;45:33–43.
Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis. 2003-12 JAMA Surg. 2014;149:275–87.
Kim G, Tan CS, Tan KW, Lim SPY, So JBY, Shabbir A. Sleeve Ggastrectomy and Roux-En-Y Gastric bypass lead to comparable changes in body composition in a multiethnic asian population. J Gastrointest Surg: Off J Soc Surg Alimentary Trac. 2019;23:445–50.
Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017;27:2279–89.
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427–36.
Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94.
Ferraz ÁAB, Carvalho MRC, Siqueira LT, Santa-Cruz F, Campos JM. Micronutrient deficiencies following bariatric surgery: a comparative analysis between sleeve gastrectomy and Roux-en-Y gastric bypass. Rev do Col Brasileiro de Cirurgioes. 2018;45:e2016.
Gu L, Fu R, Chen P, Du N, Chen S, Mao D, et al. In terms of nutrition, the most suitable method for bariatric surgery: laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass? A systematic review and meta-analysis. Obes Surg. 2020;30:2003–14.
Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association Of Clinical Endocrinologists and American College Of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients With Obesity. Endocr Pract: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2016;22(Suppl 3):1–203.
Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes care. 2006;29:1130–9.
González-Salazar LE, Pichardo-Ontiveros E, Palacios-González B, Vigil-Martínez A, Granados-Portillo O, Guizar-Heredia R, et al. Effect of the intake of dietary protein on insulin resistance in subjects with obesity: a randomized controlled clinical trial. Eur J Nutr. 2021;60:2435–47.
Wang X, Ma B, Li G, Sheng C, Yang P, Gao J, et al. Glucose-lipid metabolism in obesity with elevated prolactin levels and alteration of prolactin levels after laparoscopic sleeve gastrectomy. Obes Surg. 2020;30:4004–13.
Huang X, Li G, Xu B, Zhang J, Wang X, Cheng X, et al. Lower baseline serum triglyceride levels are associated with higher decrease in body mass index after laparoscopy sleeve gastrectomy among obese patients. Front Endocrinol. 2021;12:633856.
Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22:463–93.
Young JI, Züchner S, Wang G. Regulation of the Epigenome by Vitamin C. Annu Rev Nutr. 2015;35:545–64.
Carr AC, Maggini S: Vitamin C and immune function. Nutrients 2017;91211.
Pearson JF, Pullar JM, Wilson R, Spittlehouse JK, Vissers MCM, Skidmore PML, et al: Vitamin C status correlates with markers of metabolic and cognitive health in 50-year-olds: findings of the CHALICE Cohort Study. Nutrients 2017;9:831.
Ellulu MS, Rahmat A, Patimah I, Khaza’ai H, Abed Y. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Drug Des, Dev Ther. 2015;9:3405–12.
Yoon M. The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions. Pharmacol Res. 2009;60:151–9.
Lee H, Ahn J, Shin SS, Yoon M. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice. Int J Obes (2005). 2019;43:1620–30.
McRae MP. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med. 2008;7:48–58.
Ashor AW, Siervo M, van der Velde F, Willis ND, Mathers JC. Systematic review and meta-analysis of randomised controlled trials testing the effects of vitamin C supplementation on blood lipids. Clin Nutr (Edinb, Scotl). 2016;35:626–37.
Ascorbic acid and the catabolism of cholesterol. Nutr Rev. 1973;31:154–6.
Charlton-Menys V, Durrington PN. Human cholesterol metabolism and therapeutic molecules. Exp Physiol. 2008;93:27–42.
Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis: Off J Natl Kidney Found. 2003;41:S4–12.
Reda E, D’Iddio S, Nicolai R, Benatti P, Calvani M. The carnitine system and body composition. Acta diabetologica. 2003;40(Suppl 1):S106–113.
Afkhami-Ardekani M, Shojaoddiny-Ardekani A. Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients. Indian J Med Res. 2007;126:471–4.
Peluso I, Villano DV, Roberts SA, Cesqui E, Raguzzini A, Borges G, et al. Consumption of mixed fruit-juice drink and vitamin C reduces postprandial stress induced by a high fat meal in healthy overweight subjects. Curr Pharm Des. 2014;20:1020–4.
Yamada C, Kishimoto N, Urata N, Kimura M, Toyoda M, Masuda Y, et al. Relationship between Serum Antioxidative Vitamin Concentrations and Type 2 Diabetes in Japanese Subjects. J nutritional Sci Vitaminol. 2020;66:289–95.
Ashor AW, Werner AD, Lara J, Willis ND, Mathers JC, Siervo M. Effects of vitamin C supplementation on glycaemic control: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr. 2017;71:1371–80.
Zhang Y, Ren J. Corrigendum to “Thapsigargin triggers cardiac contractile dysfunction via NADPH oxidase-mediated mitochondrial dysfunction: Role of Akt dephosphorylation” [Free Radic. Biol. Med. 51(12) (2011) 2172-84]. Free Radic Biol Med. 2018;117:259–61.
Kaźmierczak-Barańska J, Boguszewska K, Adamus-Grabicka A, Karwowski BT: Two faces of Vitamin C-antioxidative and pro-oxidative agent. Nutrients 2020;12:1501.
Qing Z, Xiao-Hui W, Xi-Mei W, Chao-Chun Z. Vitamin C deficiency aggravates tumor necrosis factor α-induced insulin resistance. Eur J Pharmacol. 2018;829:1–11.
Dakhale GN, Chaudhari HV, Shrivastava M. Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci. 2011;2011:195271.
Gundala NKV, Naidu VGM, Das UN. Amelioration of streptozotocin-induced type 2 diabetes mellitus in Wistar rats by arachidonic acid. Biochemical biophysical Res Commun. 2018;496:105–13.
Das UN. Vitamin C for Type 2 Diabetes mellitus and hypertension. Arch Med Res. 2019;50:11–14.
Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049–57.
Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Lucchese M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168:829–43.
Freitas WR Jr, Oliveira LVF, Perez EA, Ilias EJ, Lottenberg CP, et al. Systemic inflammation in severe obese patients undergoing surgery for obesity and weight-related diseases. Obes Surg. 2018;28:1931–42.
Wang X, Sun H, Ma B, Gao J, Yin J, Qu S. Insulin-like growth Factor 1 related to chronic low-grade inflammation in patients with obesity and early change of its levels after laparoscopic sleeve gastrectomy. Obes Surg. 2020;30:3326–32.
Galan P, Viteri FE, Bertrais S, Czernichow S, Faure H, Arnaud J, et al. Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr. 2005;59:1181–90.
Canoy D, Wareham N, Welch A, Bingham S, Luben R, Day N, et al. Plasma ascorbic acid concentrations and fat distribution in 19,068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study. Am J Clin Nutr. 2005;82:1203–9.
Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK. Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed: Medscape Gen Med. 2006;8:59.
Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arteriosclerosis, thrombosis, Vasc Biol. 2003;23:434–9.
Riess KP, Farnen JP, Lambert PJ, Mathiason MA, Kothari SN. Ascorbic acid deficiency in bariatric surgical population. Surg Obes Relat Dis: Off J Am Soc Bariatr Surg. 2009;5:81–86.
Acknowledgements
The authors are grateful to all the participants of this study for their contributions. The research was supported by the Climbing Talent Program of Shanghai Tenth People’s Hospital (2021SYPDRC047)
Author information
Authors and Affiliations
Contributions
JY was responsible for conducting the research and writing the protocol and report. LD conducted the analyses of the data. CS and HY collected the data. XW and SQ designed the research protocol.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yin, J., Du, L., Sheng, C. et al. Vitamin C status and its change in relation to glucose-lipid metabolism in overweight and obesity patients following laparoscopic sleeve gastrectomy. Eur J Clin Nutr 76, 1387–1392 (2022). https://doi.org/10.1038/s41430-022-01134-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-022-01134-1